- Title
- 3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD
- Creators - without role
- Celeste Porsbjerg - Bispebjerg HospitalAnke Maitland-van Der Zee - University of AmsterdamGuy Brusselle - Ghent University HospitalGiorgio Walter Canonica - Humanitas UniversityAlvar Agusti - Consorci Institut D'Investigacions Biomediques August Pi I SunyerRosa Faner - Universitat de BarcelonaClaus Vogelmeier - German Center for Lung ResearchMartijn Nawijn - University of GroningenMaarten van den Berge - University Medical Center GroningenFranca Rusconi - Meyer Children's HospitalCharles Pilette - Cliniques Universitaires Saint-LucValeria Ramiconi - European Federation of Allergy and Airways Diseases Patients AssociationsCourtney Coleman - British Lung FoundationRekha Chaudhuri - University of GlasgowKian Fan Chung - Imperial College LondonJadwiga Wedzicha - Imperial College LondonSejla Saglani - Imperial College LondonMarc van Der Schee - Owlstone MedicalLiam Heaney - Queen's University BelfastArnaud Bourdin - Université de Montpellier, Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExpGraham Roberts - David Hide Asthma and Allergy Research CentreRatko Djukanovic - NIHR Southampton Biomedical Research CentrePiotr Kuna - Medical University of LodzMaceij Kupczyk - University of ŁódźJudith Axmann - RocheHeribert Staudinger - SanofiGraham Clarke - AstraZenecaSven Erik Dahlen - Karolinska University HospitalChris Brightling - University of Leicester
- Publication Details
- European Respiratory Journal, Vol.58(4)
- Identifiers
- 9943751709311
- Academic Unit
- Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-03403437
Journal article
3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD
European Respiratory Journal, Vol.58(4)
21/10/2021
Metrics
1 Record Views